• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,785
2,304
2,237
1,864
1,727

COUNTRY

1,033
871
272
254
210

CATEGORIES

  • 858
  • 186
  • 679
  • 1,127
  • 398
  • 270
  • 255
  • 66
  • 382
  • 725
  • 1,339
  • 1,356
  • 626
  • 884
  • 1,706
  • 2,689
  • 507
  • 732
  • 0
  • 93

PRICE

7,471
12,545
20,252
26,480

PUBLISHED

2,902
3,769
8,291
26,480

PRODUCT TYPE

21,606
2,901
872
827
164
44
21
21
17
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

China Heparin Industry Report, 2013-2015

Since the small intestines of pigs (raw materials for production of heparin) in China are abundant (the pig slaughtering volume in China approximates 50% of globe's total) and heparin APIs are gradually...

October 2013
FROM

Understanding Health Communication Technologies. Jossey-Bass Public Health

Understanding Health Communications Technologies provides a hands-on guide for students and professionals for effective investment in deployment  of management of communication technologies in health...

October 2013

China Heparin Industry Report, 2013-2015

Since the small intestines of pigs (raw materials for production of heparin) in China are abundant (the pig slaughtering volume in China approximates 50% of globe's total) and heparin APIs are gradually...

October 2013
FROM
PARP Inhibitors - A new class of targeted cancer therapies PARP Inhibitors - A new class of targeted cancer therapies - Product Thumbnail Image

PARP Inhibitors - A new class of targeted cancer therapies

Poly (ADP-ribose) polymerase (PARP) enzymes are involved in repairing DNA PARP inhibition leads to synthetic lethality because only an error prone repair pathway is left to repair DNA damage For this...

October 2013
FROM
Transcriptomics Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Transcriptomics Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 - Product Thumbnail Image

Transcriptomics Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

'Transcriptomics Technologies Market (Microarrays, PCR, Gene Regulation and Next Generation Sequencing) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019' Transcriptomics...

October 2013
FROM

Spain Pharmaceuticals and Healthcare Report Q4 2013

Despite the transfer of the financial burden of healthcare from the state to the patient going against the aim of most developed-state governments to provide social welfare, BMI believes the success...

October 2013
Atrial Fibrillation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Atrial Fibrillation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 - Product Thumbnail Image

Atrial Fibrillation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

'Atrial Fibrillation Market (Pharmacological and Non-Pharmacological Treatment, Electric Cardioversion, Radiofrequency, Cryo, Laser and Microwave Catheter Ablation, Maze Surgery, Anti-Coagulant and...

October 2013
FROM

Ghana Pharmaceuticals and Healthcare Report Q4 2013

BMI View: Ghana is in a geographically favourable position, with the potential to convert its pharmaceutical sector into a regional leader. The government certainly has ambitions to achieve this. It...

October 2013
Therapy Class Overview : Hepatitis C Virus Infection Therapy Class Overview : Hepatitis C Virus Infection - Product Thumbnail Image

Therapy Class Overview : Hepatitis C Virus Infection

Freedom from injecting Interferon (IFN), treating major HCV genotypes WW and betting on vaccines could bring a sea of change in the treatment of HCV infection in the future This year the first IFN-free...

October 2013
FROM
Therapy Class Overview : Rituximab biosimilar Therapy Class Overview : Rituximab biosimilar - Product Thumbnail Image

Therapy Class Overview : Rituximab biosimilar

Approval of Inflectra/Remsima, the first biosimilar Monoclonal antibody (Mab) from Celltrion and Hospira in EU in 2013 is a trend setter! Inflectra is a biosimilar of Johnson & Johnson's Remicade, which...

October 2013
FROM

2014 U.S. Pharmaceutical Preparation Manufacturing. Industry-Industry & Market Report

The 2014 U S Pharmaceutical Preparation Manufacturing Industry-Industry & Market report, published annually , contains timely and accurate industry statistics, forecasts and demographics The report...

October 2013
FROM

2014 U.S. Pharmacies & Drug Stores Industry-Industry & Market Report

The 2014 U.S. Pharmacies & Drug Stores Industry-Industry & Market report, published annually , contains timely and accurate industry statistics, forecasts and demographics. The report features 2014...

October 2013
FROM

Global Mobile Health Solution Market 2012-2016

The analysts forecast the Global Mobile Health Solution market to grow at a CAGR of 42.40 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing...

October 2013
FROM

Global Hyaluronic Market 2012-2016

The analysts forecast the Global Hyaluronic Acid market to grow at a CAGR of 9.39 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rise in aging population....

October 2013
FROM

Switzerland Pharmaceuticals and Healthcare Report Q4 2013

BMI View: The 2012-2017 forecast period is likely to witness the proliferation of government initiatives supporting the growth of Switzerland's generic medicines market, which will increasingly attract...

October 2013

Chile Pharmaceuticals and Healthcare Report Q4 2013

BMI View: Despite the slowdown in economic growth, Chile has accelerated the pace it is improving public healthcare standards at. However, poor quality medicines still proliferate in Chile's pharmaceutical...

October 2013

Proteasome Inhibitors Market

The market for proteasome inhibitors is experiencing rapid transformation Amgen’s acquisition of Onyx Pharmaceuticals, developer of Kyprolis, for $10 4 billion comes just five years after Takeda paid...

October 2013
FROM

France Pharmaceuticals and Healthcare Report Q4 2013

BMI View: We expect pressures on the French government to mount over the coming quarters encouraging it to engage in more concerted fiscal consolidation, particularly as lower growth begins to translate...

October 2013

Company Snapshot – Abbott India Limited

This company snapshot provides an overall assessment of the company and its progress It describes management type and share holding pattern, categories of businesses and subsidiaries, financial and...

October 2013
FROM

South Africa Pharmaceuticals and Healthcare Report Q4 2013

BMI View: This quarter has seen local generic drugmaker Adcock Ingram receive two further non-binding proposals for the company's takeover, highlighting the long-term commercial opportunities represented...

October 2013
Loading Indicator

Our Clients

Our clients' logos